248 related articles for article (PubMed ID: 24289327)
1. Denosumab in osteoporosis.
Diab DL; Watts NB
Expert Opin Drug Saf; 2014 Feb; 13(2):247-53. PubMed ID: 24289327
[TBL] [Abstract][Full Text] [Related]
2. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
3. [Updates of denosumab, anti-RANKL antibody for osteoporosis].
Tokuyama N; Tanaka S
Clin Calcium; 2014 Jan; 24(1):85-91. PubMed ID: 24369284
[TBL] [Abstract][Full Text] [Related]
4. Denosumab for the reduction of bone loss in postmenopausal osteoporosis: a review.
Bridgeman MB; Pathak R
Clin Ther; 2011 Nov; 33(11):1547-59. PubMed ID: 22108301
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of denosumab for treatment of bone loss in men and women.
Adler RA; Gill RS
Clin Interv Aging; 2011; 6():119-24. PubMed ID: 21753866
[TBL] [Abstract][Full Text] [Related]
6. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis.
Josse R; Khan A; Ngui D; Shapiro M
Curr Med Res Opin; 2013 Mar; 29(3):205-16. PubMed ID: 23297819
[TBL] [Abstract][Full Text] [Related]
7. Denosumab: in cancer treatment-induced bone loss.
Muir VJ; Scott LJ
BioDrugs; 2010 Dec; 24(6):379-86. PubMed ID: 21043545
[TBL] [Abstract][Full Text] [Related]
8. Denosumab in osteoporosis and oncology.
Burkiewicz JS; Scarpace SL; Bruce SP
Ann Pharmacother; 2009 Sep; 43(9):1445-55. PubMed ID: 19622756
[TBL] [Abstract][Full Text] [Related]
9. Denosumab. Limited efficacy in fracture prevention, too many adverse effects.
Prescrire Int; 2011 Jun; 20(117):145-8. PubMed ID: 21678700
[TBL] [Abstract][Full Text] [Related]
10. Denosumab--an emerging treatment for postmenopausal osteoporosis.
Lewiecki EM
Expert Opin Biol Ther; 2010 Mar; 10(3):467-76. PubMed ID: 20095877
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
Ellis GK; Bone HG; Chlebowski R; Paul D; Spadafora S; Smith J; Fan M; Jun S
J Clin Oncol; 2008 Oct; 26(30):4875-82. PubMed ID: 18725648
[TBL] [Abstract][Full Text] [Related]
12. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
[TBL] [Abstract][Full Text] [Related]
13. Denosumab update.
Lewiecki EM
Curr Opin Rheumatol; 2009 Jul; 21(4):369-73. PubMed ID: 19424068
[TBL] [Abstract][Full Text] [Related]
14. The clinical use of denosumab for the management of low bone mineral density in postmenopausal women.
Harris KB; Nealy KL; Jackson DJ; Thornton PL
J Pharm Pract; 2012 Jun; 25(3):310-8. PubMed ID: 22550161
[TBL] [Abstract][Full Text] [Related]
15. Treatment of osteoporosis with denosumab.
Lewiecki EM
Maturitas; 2010 Jun; 66(2):182-6. PubMed ID: 20236778
[TBL] [Abstract][Full Text] [Related]
16. The role and efficacy of denosumab in the treatment of osteoporosis: an update.
Charopoulos I; Orme S; Giannoudis PV
Expert Opin Drug Saf; 2011 Mar; 10(2):205-17. PubMed ID: 21208140
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of denosumab for the treatment for postmenopausal osteoporosis.
Lewiecki EM
Curr Med Res Opin; 2010 Dec; 26(12):2807-12. PubMed ID: 21050058
[TBL] [Abstract][Full Text] [Related]
18. New and emerging concepts in the use of denosumab for the treatment of osteoporosis.
Lewiecki EM
Ther Adv Musculoskelet Dis; 2018 Nov; 10(11):209-223. PubMed ID: 30386439
[TBL] [Abstract][Full Text] [Related]
19. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab.
Tarantino U; Celi M; Feola M; Liuni FM; Resmini G; Iolascon G
Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S65-9. PubMed ID: 24046047
[TBL] [Abstract][Full Text] [Related]
20. Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.
McClung MR; Boonen S; Törring O; Roux C; Rizzoli R; Bone HG; Benhamou CL; Lems WF; Minisola S; Halse J; Hoeck HC; Eastell R; Wang A; Siddhanti S; Cummings SR
J Bone Miner Res; 2012 Jan; 27(1):211-8. PubMed ID: 21976367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
